Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$7.96 - $12.37 $75,532 - $117,378
9,489 Added 91.04%
19,912 $210,000
Q4 2023

Feb 14, 2024

SELL
$4.9 - $12.86 $5,140 - $13,490
-1,049 Reduced 9.14%
10,423 $125,000
Q3 2023

Nov 14, 2023

BUY
$7.0 - $11.26 $10,689 - $17,194
1,527 Added 15.35%
11,472 $80,000
Q2 2023

Aug 14, 2023

BUY
$7.61 - $9.46 $57,211 - $71,120
7,518 Added 309.77%
9,945 $84,000
Q1 2023

May 12, 2023

BUY
$8.83 - $17.61 $21,430 - $42,739
2,427 New
2,427 $22,000
Q3 2022

Nov 14, 2022

BUY
$16.06 - $26.39 $34,239 - $56,263
2,132 New
2,132 $36,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.